Edesa Biotech Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	TTM	FY 2025	FY 2024	FY	FY
Period Ending	Dec '25 Dec 31, 2025	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Aug '12 Aug 31, 2012	Aug '11 Aug 31, 2011
Cash & Equivalents	12.05	10.79	1.04	1.01	4.24
Cash & Short-Term Investments	12.05	10.79	1.04	1.01	4.24
Cash Growth	670.82%	940.39%	2.53%	-76.12%	-
Accounts Receivable	0.43	0.64	0.27	0.02	0.04
Other Current Assets	0.23	0.08	0.37	0.03	0.04
Total Current Assets	12.72	11.51	1.68	1.06	4.31
Net Property, Plant & Equipment	-	-	0.02	0.34	0.35
Other Intangible Assets	1.95	1.98	2.08	0.15	0.18
Other Long-Term Assets	0.04	0.04	0.04	0.02	0.02
Total Assets	14.71	13.53	3.81	1.56	4.86
Accounts Payable	0.76	1.08	1.81	0.44	0.16
Current Portion of Leases	-	-	0.02	-	-
Unearned Revenue	-	-	-	0.13	-
Total Current Liabilities	0.76	1.08	1.83	0.57	0.16
Other Long-Term Liabilities	-	-	-	0.13	1.56
Total Long-Term Liabilities	-	-	-	0.13	1.56
Total Liabilities	0.76	1.08	1.83	0.7	1.72
Preferred Stock	9.3	9.26	-	-	-
Common Stock	57.9	54.52	47.24	9.63	7.35
Additional Paid-in Capital	15.12	14.75	13.58	1.68	1.01
Accumulated Other Comprehensive Income	-0.17	-0.17	-0.24	-	-
Retained Earnings	-68.2	-65.91	-58.59	-10.45	-5.23
Shareholders' Equity	13.95	12.45	1.98	0.86	3.13
Total Liabilities & Equity	14.71	13.53	3.81	1.56	4.86
Total Debt	-	0	0.02	0	0
Net Cash (Debt)	12.05	10.79	1.02	1.01	4.24
Net Cash Growth	11.67%	960.70%	0.56%	-76.12%	-
Net Cash Per Share	1.76	1.90	0.32	0.02	0.11
Book Value	13.95	12.45	1.98	0.86	3.13
Book Value Per Share	2.04	2.19	0.62	0.02	0.08
Tangible Book Value	12	10.47	-0.1	0.72	2.95
Tangible Book Value Per Share	1.75	1.85	-0.03	0.02	0.08

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q